THB Asset Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

THB Asset Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-46,453	Closed	-$2.65M	–	197
2019 Q4	$2.65M	Sell	46,453 -35,502	-43%	-$1.88M	0.49%	73
2019 Q3	$4.39M	Sell	81,955 -1,805	-2%	-$105K	0.81%	53
2019 Q2	$5M	Sell	83,760 -3,731	-4%	-$235K	0.8%	53
2019 Q1	$5.45M	Sell	87,491 -6,029	-6%	-$399K	0.79%	56
2018 Q4	$5.67M	Sell	93,520 -19,965	-18%	-$1.19M	0.84%	48
2018 Q3	$6.64M	Sell	113,485 -450	-0.4%	-$23K	0.81%	51
2018 Q2	$5.11M	Buy	113,935 +67,565	+146%	+$2.91M	0.62%	74
2018 Q1	$2.06M	Buy	+46,370	New	+$1.95M	0.27%	97

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

THB Asset Management's BSTC Position: Q1 2020 in Review

THB Asset Management sold out of BioSpecifics Technologies Corp. (BSTC) in Q1 2020, closing a stake of 46,453 shares — an estimated $2.65M sold.

THB Asset Management first reported a position in BSTC in Q1 2018 and held it in 8 quarters. The position peaked at $6.64M in Q3 2018. 113 funds tracked by Wall St. Rank hold BSTC as of Q1 2020.

THB Asset Management reported no remaining BioSpecifics Technologies Corp. position as of Q1 2020 after selling out during the quarter.
THB Asset Management sold 46,453 BioSpecifics Technologies Corp. shares in Q1 2020, an estimated $2.65M.
THB Asset Management first reported a position in BioSpecifics Technologies Corp. in Q1 2018 and held it in 8 quarters.
THB Asset Management's BioSpecifics Technologies Corp. position peaked at $6.64M in Q3 2018.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2020.

Based on THB Asset Management's 13F filing for Q1 2020, filed 6 May 2020.